ST. LOUIS--(BUSINESS WIRE)--As a leading life sciences consulting firm offering strategic and tactical commercialization services to pharmaceutical, biotechnology and medical device manufacturers, D2 Consulting will participate at the upcoming Specialty Pharmacy Summit in Las Vegas, Nevada. President and CEO, Dean Erhardt, will present “Market Disintermediation: Mergers, Mega Players and Media Hype,” Tuesday, April 30th, 10:30 a.m., Margaux Room.
“We are honored to be presenting at this year’s Summit and interact with the key players in the specialty pharmacy industry,” says Erhardt. “During my presentation, attendees can expect to learn more about the role of payers in the emerging value-based payment models for specialty pharmacy as well as the impact on pharmaceutical and medical device manufacturers for delivering value. The changing landscape that includes emerging technology providers, new payer organizations resulting from mergers and acquisitions, and new participants, requires greater understanding of market changes. During this session, I will provide guidance on how manufacturers might consider changing market dynamics.”
This 15th annual Specialty Pharmacy Summit welcomes thousands of senior executives, key decision makers and other industry professionals. Organizations being represented include pharmacies, health systems, pharma/biotech manufacturers, drug wholesalers, health plans, consulting firms, along with others.
Erhardt continues, “Discussions will include current perspectives, collected via multiple industry interviews and interactions on the today and tomorrow of a very changing market and how these changes might impact product launch considerations. The complexities of a changing market require innovative thinking, a fresh approach and the guidance of experts who understand the nuances. Contract negotiations reflect a new set of parameters and there’s simply no time for making avoidable errors.”
To schedule a meeting with the D2 team, contact Darren Stefano or visit Booth 501.
About D2 Consulting
D2 Consulting is a leading provider of commercialization services to the healthcare and life sciences industries, D2 works across all stakeholders including manufacturers, payers and channel participants to execute strategic business initiatives that ensure successful launch, distribution and reimbursement to maximize market impact and support an ongoing leadership position in the marketplace. Visit http://d2rx.com/.
